HUMA – humacyte, inc. (US:NASDAQ)
Stock Stats
News
Humacyte To Participate in Upcoming Investor Conferences [Yahoo! Finance]
Humacyte To Participate in Upcoming Investor Conferences
Humacyte (NASDAQ:HUMA) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $25.00 price target on the stock.
Humacyte Announces Presentation of Symvess® Long-Term Safety and Efficacy Results at VESS Meeting
Humacyte (HUMA) Valuation Check As DoD Funding Highlights Symvess Battlefield Trauma Potential [Yahoo! Finance]
Form SCHEDULE 13D/A Humacyte, Inc. Filed by: Fresenius Medical Care AG
Form 8-K Humacyte, Inc. For: Dec 16
Form 424B5 Humacyte, Inc.
Form 8-K Humacyte, Inc. For: Dec 15
Form 8-K Humacyte, Inc. For: Dec 15
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.